Atherosclerosis
News, opinions and meeting coverage in cardiology.
<ѻýҕl>Fatty Liver Tied to Diabetes, Atherosclerosisѻýҕl>
LONDON -- Non-alcoholic fatty liver disease (NAFLD) is an independent predictor of both type 2 diabetes and carotid atherosclerosis, according to two studies presented here at the annual meeting of the European Association for the Study of the Liver.
Apr 11, 2014
<ѻýҕl>Anatomy of an Epidemic: The Opioid Movieѻýҕl>
The national clamor over abuse of prescription opioids is now at a fever pitch, but little has been said about what drove the boon in opioid prescriptions. This latest report from ѻýҕl/ Milwaukee Journal Sentinel analyzes a pivotal Oxycontin marketing video, it's impact and its aftermath.
Sep 09, 2012
<ѻýҕl>Diet, Exercise Sufficient to Reduce Triglyceridesѻýҕl>
While cholesterol control is often balanced between statins and lifestyle changes, reducing triglycerides can usually be accomplished with diet and lifestyle changes alone, according to a new scientific statement from the American Heart Association.
Apr 20, 2011
<ѻýҕl>Cardiologist Who Revealed Echo Errors Out of a Jobѻýҕl>
MILWAUKEE -- A cardiologist whose research at a national medical meeting revealed that other doctors at her hospital were misreading a substantial number of diagnostic echocardiograms has been fired by that hospital, the Journal Sentinel and ѻýҕl have learned.
Jan 14, 2011
<ѻýҕl>ACC: Triglycerides Decreased with Rosuvastatin Therapyѻýҕl>
ATLANTA -- In a study that specifically scrutinized the effects of statin therapy on triglycerides, researchers said that rosuvastatin (Crestor) significantly reduced the blood lipid that has been linked to coronary artery disease better than placebo.
Mar 15, 2010
<ѻýҕl>ACC: Clopidogrel Black Box Likely to Have Immediate Clinical Impactѻýҕl>
ATLANTA -- The FDA's decision to add a black box warning to the label of clopidogrel (Plavix) came without warning to doctors attending the American College of Cardiology meeting here. But getting the word out to more than 13,000 cardiologists gathered in this city not an easy task.
Mar 14, 2010
<ѻýҕl>AHA: FDA Drops Clopidogrel Bomb at AHAѻýҕl>
ORLANDO -- The FDA has issued a public health advisory warning patients and physicians that concommitant use of clopidogrel (Plavix) and omeprazole (Prilosec and Prilosec OTC) blunts the antiplatelet effect of clopidogrel, so the combination should be avoided.
Nov 17, 2009
<ѻýҕl>ESC: Peto Analysis Called Short on Proof of Simvastatin/ Ezetimibe Cancer Safetyѻýҕl>
SEATTLE -- Simvastatin/ezetimibe (Vytorin) may increase the risk of cancer after all, concluded a leading American biostatistician who dismissed as prematurely reassuring an analysis by Richard Peto, Ph.D., F.R.S., that found the link with excess malignancy to be overblown.
Sep 04, 2008
<ѻýҕl>ASNC: Caffeine Screens Before Stress Tests Often Miss Positives
ѻýҕl>
SAN DIEGO -- Routine screening by questionnaire for caffeine intake before pharmacologic cardiac stress testing fails to identify most patients who have detectable serum levels of the stimulant, investigators said here.
Sep 12, 2007